-
CSBR Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Champions Oncology (CSBR)
Company Profile
Quarter (USD) | Oct 24 | Jul 24 | Apr 24 | Jan 24 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Apr 24 | Apr 23 | Apr 22 | Apr 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 2.75 mm | 2.75 mm | 2.75 mm | 2.75 mm | 2.75 mm | 2.75 mm |
Cash burn (monthly) | 46.00 k | 229.92 k | (no burn) | 64.58 k | 94.33 k | 222.50 k |
Cash used (since last report) | 152.05 k | 759.97 k | n/a | 213.47 k | 311.81 k | 735.45 k |
Cash remaining | 2.60 mm | 1.99 mm | n/a | 2.54 mm | 2.44 mm | 2.02 mm |
Runway (months of cash) | 56.6 | 8.7 | n/a | 39.3 | 25.9 | 9.1 |
13F holders | Current |
---|---|
Total holders | 15 |
Opened positions | 6 |
Closed positions | 0 |
Increased positions | 1 |
Reduced positions | 2 |
13F shares | Current |
---|---|
Total value | 18.59 bn |
Total shares | 6.25 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Battery Management | 2.42 mm | $11.79 bn |
New Enterprise Associates 14 | 1.71 mm | $9.37 mm |
Tocqueville Asset Management | 705.21 k | $3.43 bn |
West Elk Partners | 676.94 k | $6.40 mm |
Vanguard | 307.00 k | $1.50 bn |
Renaissance Technologies | 119.99 k | $584.36 mm |
BlackRock | 116.19 k | $565.85 mm |
Geode Capital Management | 65.06 k | $316.93 mm |
NTRS Northern Trust | 41.07 k | $200.02 mm |
Acadian Asset Management | 30.70 k | $148.00 k |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
12 Nov 24 | Ackerman Joel | Option to purchase Common Stock Common Stock | Grant | Acquire A | No | No | 4.64 | 43,190 | 200.40 k | 43,190 |
12 Nov 24 | Tobin Scott R | Option to purchase Common Stock Common Stock | Grant | Acquire A | No | No | 4.64 | 34,550 | 160.31 k | 34,550 |
12 Nov 24 | Mendelson Daniel Newman | Option to purchase Common Stock Common Stock | Grant | Acquire A | No | No | 4.64 | 21,590 | 100.18 k | 21,590 |
12 Nov 24 | Sidransky David | Option to purchase Common Stock Common Stock | Grant | Acquire A | No | No | 4.64 | 21,880 | 101.52 k | 21,880 |
12 Nov 24 | Philip P. Breitfeld | Option to purchase Common Stock Common Stock | Grant | Acquire A | No | No | 4.64 | 18,715 | 86.84 k | 18,715 |